Keryx Biopharmaceuticals, Inc. Gross Margin 2010-2018 | KERX
Current and historical gross margin for Keryx Biopharmaceuticals, Inc. (KERX) over the last 10 years. The current gross profit margin for Keryx Biopharmaceuticals, Inc. as of September 30, 2018 is %.
| Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2018-09-30 | $0.10B | $0.06B | 61.05% |
| 2018-06-30 | $0.08B | $0.05B | 56.10% |
| 2018-03-31 | $0.07B | $0.04B | 54.93% |
| 2017-12-31 | $0.06B | $0.04B | 57.38% |
| 2017-09-30 | $0.05B | $0.02B | 38.46% |
| 2017-06-30 | $0.04B | $-0.00B | -2.33% |
| 2017-03-31 | $0.04B | $-0.01B | -18.92% |
| 2016-12-31 | $0.03B | $-0.01B | -28.13% |
| 2016-09-30 | $0.03B | $0.00B | 0.00% |
| 2016-06-30 | $0.03B | $0.01B | 53.85% |
| 2016-03-31 | $0.02B | $0.01B | 60.00% |
| 2015-12-31 | $0.01B | $0.01B | 57.14% |
| 2015-09-30 | $0.01B | $0.00B | 44.44% |
| 2015-06-30 | $0.01B | $0.00B | 60.00% |
| 2014-12-31 | $0.01B | $0.01B | 90.91% |
| 2009-12-31 | $0.03B | $0.03B | 100.00% |
